MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.49
0.04 (9.82%)
ā²
5d:
+9.09%
30d:
-27.59%
90d:
-69.32%
BUY
HIGH Confidence
Analysis Updated: Apr 6, 2026 12:00 AM ET
Earnings: May 11, 2026
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
ā BUY SIGNAL: MDCX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
ā BUY SIGNAL: MDCX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.49, which is considered fair relative to its 30-day fair value range of $0.29 to $1.04.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.39, while resistance sits at $0.51. The stock is showing strong short-term momentum, up 9.8% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.53 (+2045.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.39, while resistance sits at $0.51. The stock is showing strong short-term momentum, up 9.8% recently.
Market Sentiment: MDCX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.53 (+2045.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.29 -
$1.04
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.8%)
- BULLISH: Trading 2045.5% below Wall St target ($10.53)
Fair Price Analysis
30-Day Fair Range
$0.29 -
$1.04
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.39
Resistance Level
$0.51
Current Trend
Strong Downtrend
Technical data as of
Apr 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.97
Wall Street Target
$10.53
(+2045.5%)
Share & Embed Analysis
Last updated: April 07, 2026 12:41 AM ET
Data refreshes hourly during market hours. Next update: 1:41 AM
Data refreshes hourly during market hours. Next update: 1:41 AM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1209 | 58 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 59 HOLD |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$249 | 60 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$351 | 56 HOLD |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$128 | 63 BUY |
